(Q45879506)

17 December 2017

review article

1 reference

title

A realistic chance for gene therapy in the near future (English)

1 reference

17 December 2017

0 references

Stefan Worgall

1

1 reference

17 December 2017

publication date

10 November 2004

1 reference

17 December 2017

published in

Pediatric Nephrology

1 reference

17 December 2017

volume

20

1 reference

17 December 2017

issue

2

1 reference

17 December 2017

page(s)

118-124

1 reference

17 December 2017

Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease

cites work

1 reference

12 December 2020

Clinical gene transfer studies for hemophilia B.

1 reference

12 December 2020

AAV-based gene transfer

1 reference

12 December 2020

Gene therapy with recombinant adenovirus vectors: evaluation of the host immune response

1 reference

12 December 2020

Modification to the capsid of the adenovirus vector that enhances dendritic cell infection and transgene-specific cellular immune responses

1 reference

12 December 2020

Gene therapy for human malignant brain tumors.

1 reference

12 December 2020

Molecular biology of adeno-associated viruses

1 reference

12 December 2020

Immune responses to replication-defective HSV-1 type vectors within the CNS: implications for gene therapy

1 reference

12 December 2020

Efficient mobilization and recruitment of marrow-derived endothelial and hematopoietic stem cells by adenoviral vectors expressing angiogenic factors

1 reference

12 December 2020

Transcription start regions in the human genome are favored targets for MLV integration

1 reference

12 December 2020

Applications of gene therapy to kidney disease

1 reference

12 December 2020

Prospects and implications of using chromatin insulators in gene therapy and transgenesis

1 reference

12 December 2020

Gene delivery by lentivirus vectors an overview.

1 reference

12 December 2020

Genetically modified bone marrow-derived vehicle cells site specifically deliver an anti-inflammatory cytokine to inflamed interstitium of obstructive nephropathy

1 reference

12 December 2020

Phase I trial of intramuscular injection of a recombinant adeno-associated virus alpha 1-antitrypsin (rAAV2-CB-hAAT) gene vector to AAT-deficient adults

1 reference

12 December 2020

CTLA4Ig gene transfer prolongs survival and induces donor-specific tolerance in a rat renal allograft

1 reference

12 December 2020

AAV-mediated gene transfer to skeletal muscle.

1 reference

12 December 2020

Adeno-associated viruses undergo substantial evolution in primates during natural infections

1 reference

12 December 2020

Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain

1 reference

12 December 2020

AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B.

1 reference

12 December 2020

Gene delivery using human cord blood-derived CD34+cells into inflamed glomeruli in NOD/SCID mice

1 reference

12 December 2020

High-capacity 'gutless' adenoviral vectors.

1 reference

12 December 2020

Non-invasive liposome-mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice

1 reference

12 December 2020

Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning

1 reference

12 December 2020

Evidence that bone morphogenetic protein 4 has multiple biological functions during kidney and urinary tract development

1 reference

12 December 2020

Gene therapy using an adenovirus vector for apoptosis-related genes is a highly effective therapeutic modality for killing glioma cells

1 reference

12 December 2020

Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency

1 reference

12 December 2020

Targeting survival: integration site selection by retroviruses and LTR-retrotransposons

1 reference

12 December 2020

Comparison of replication-selective, oncolytic viruses for the treatment of human cancers.

1 reference

12 December 2020

Favorable effect of cotransfection with TGF-beta and CTLA4Ig of the donor kidney on allograft survival

1 reference

12 December 2020

Current status of gene therapy for inherited lung diseases

1 reference

12 December 2020

Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease

1 reference

12 December 2020

From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy

1 reference

12 December 2020

Clinical protocol. Gene therapy of Canavan disease: AAV-2 vector for neurosurgical delivery of aspartoacylase gene (ASPA) to the human brain

1 reference

12 December 2020

Transduction of renal cells in vitro and in vivo by adeno-associated virus gene therapy vectors.

1 reference

12 December 2020

Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates

1 reference

12 December 2020

The basic science of gene therapy

1 reference

12 December 2020

Renal gene transfer: nonviral approaches

1 reference

12 December 2020

Sustained phenotypic correction of hemophilia B dogs with a factor IX null mutation by liver-directed gene therapy

1 reference

12 December 2020

Bone marrow stem cells contribute to healing of the kidney

1 reference

12 December 2020

Gene therapy in renal diseases.

1 reference

12 December 2020

Immunity to adeno-associated virus serotype 2 delivered transgenes imparted by genetic predisposition to autoimmunity

1 reference

12 December 2020

Muscle-directed gene transfer and transient immune suppression result in sustained partial correction of canine hemophilia B caused by a null mutation

1 reference

12 December 2020

Gene therapy by transforming growth factor-beta receptor-IgG Fc chimera suppressed extracellular matrix accumulation in experimental glomerulonephritis.

1 reference

12 December 2020

A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency

1 reference

12 December 2020

A pilot study of in vivo liver-directed gene transfer with an adenoviral vector in partial ornithine transcarbamylase deficiency

1 reference

12 December 2020

1 reference

12 December 2020

Targeting retroviral and lentiviral vectors.

1 reference

12 December 2020

Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis

1 reference

12 December 2020

Antivector and antitransgene host responses in gene therapy.

1 reference

12 December 2020

Gene therapy progress and prospects: therapeutic angiogenesis for limb and myocardial ischemia

1 reference

12 December 2020

Recent advances in the development of HIV-1 vaccines using replication-incompetent adenovirus vectors

1 reference

12 December 2020

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

1 reference

12 December 2020

Gene delivery using herpes simplex virus vectors

1 reference

12 December 2020

Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity.

1 reference

12 December 2020

Molecular therapy for renal diseases

1 reference

12 December 2020

Therapeutic globin gene delivery using lentiviral vectors.

1 reference

12 December 2020

Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung

1 reference

12 December 2020

Hepatic and renal differentiation from blood-borne stem cells.

1 reference

12 December 2020

Transfer of genes to humans: early lessons and obstacles to success

1 reference

12 December 2020

Gene therapy death prompts review of adenovirus vector

1 reference

12 December 2020

Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer

1 reference

12 December 2020

Progress and problems with the use of viral vectors for gene therapy

1 reference

12 December 2020

Fas ligand gene transfer to renal allografts in rats: effects on allograft survival

1 reference

12 December 2020

Safety of local delivery of low- and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of morbid conditions

1 reference

12 December 2020

AAV-mediated gene therapy for hemophilia

1 reference

12 December 2020

A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier.

1 reference

12 December 2020

10.1007/S00467-004-1680-0

Identifiers

DOI

1 reference

17 December 2017

Dimensions Publication ID

1050301954

0 references

1 reference

17 December 2017